A different study focusing on the coagulation factor IX-Fc (FIX-Fc) fusion protein described increased immunogenicity of the FIX-Fc in comparison with the native FIX in a hemophilia B mouse model [9]. This evidence concerns the gene F9 and hemophilia B.